Verona Pharma plc (VRNA)
USD 53.82
(-7.35%)
USD 53.82
(-7.35%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -220.44 Million USD | -1.5% |
| 2022 | -217.17 Million USD | -52.33% |
| 2021 | -142.57 Million USD | 21.68% |
| 2020 | -182.03 Million USD | -531.57% |
| 2019 | -28.82 Million GBP | -14.82% |
| 2018 | -25.1 Million GBP | 40.92% |
| 2017 | -42.49 Million GBP | 13.43% |
| 2016 | -49.08 Million GBP | -840.12% |
| 2015 | -5.22 Million GBP | 66.35% |
| 2014 | -15.51 Million GBP | -1458.54% |
| 2013 | -995.64 Thousand GBP | 35.88% |
| 2012 | -1.55 Million GBP | 60.41% |
| 2011 | -3.92 Million GBP | -26.86% |
| 2010 | -3.09 Million GBP | 32.44% |
| 2009 | -4.57 Million GBP | -27.29% |
| 2008 | -3.59 Million GBP | -44.8% |
| 2007 | -2.48 Million GBP | -19.22% |
| 2006 | -2.08 Million GBP | -23.25% |
| 2005 | -1.68 Million GBP | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -203.61 Million USD | 7.63% |
| 2024 Q3 | -333.73 Million USD | -14.87% |
| 2024 Q2 | -186.06 Million USD | 8.62% |
| 2023 Q1 | -270.89 Million USD | -24.73% |
| 2023 FY | -220.44 Million USD | -1.5% |
| 2023 Q3 | -237.06 Million USD | 5.29% |
| 2023 Q2 | -250.29 Million USD | 7.6% |
| 2023 Q4 | -220.44 Million USD | 7.01% |
| 2022 FY | -217.17 Million USD | -52.33% |
| 2022 Q4 | -217.17 Million USD | 3.85% |
| 2022 Q3 | -225.87 Million USD | -113.22% |
| 2022 Q2 | -105.93 Million USD | 16.64% |
| 2022 Q1 | -127.07 Million USD | 10.87% |
| 2021 FY | -142.57 Million USD | 21.68% |
| 2021 Q1 | -163.8 Million USD | 10.02% |
| 2021 Q2 | -139.54 Million USD | 14.81% |
| 2021 Q3 | -160.23 Million USD | -14.83% |
| 2021 Q4 | -142.57 Million USD | 11.03% |
| 2020 Q3 | -200.49 Million GBP | -871.52% |
| 2020 Q4 | -182.03 Million USD | 9.2% |
| 2020 Q1 | -23.04 Million GBP | -4.82% |
| 2020 FY | -182.03 Million USD | -531.57% |
| 2020 Q2 | -20.63 Million GBP | 10.44% |
| 2019 FY | -28.82 Million GBP | -14.82% |
| 2019 Q3 | -40.24 Million GBP | -42.6% |
| 2019 Q1 | -24.1 Million GBP | 3.96% |
| 2019 Q2 | -28.22 Million GBP | -17.06% |
| 2019 Q4 | -21.98 Million GBP | 45.38% |
| 2018 Q3 | -35.9 Million GBP | 24.9% |
| 2018 Q4 | -25.1 Million GBP | 30.09% |
| 2018 FY | -25.1 Million GBP | 40.92% |
| 2018 Q1 | -40.66 Million GBP | 4.31% |
| 2018 Q2 | -47.81 Million GBP | -17.6% |
| 2017 Q3 | -42.05 Million GBP | 48.37% |
| 2017 Q4 | -42.49 Million GBP | -1.04% |
| 2017 Q2 | -81.46 Million GBP | 0.0% |
| 2017 FY | -42.49 Million GBP | 13.43% |
| 2016 FY | -49.08 Million GBP | -840.12% |
| 2016 Q4 | -49.08 Million GBP | 0.0% |
| 2016 Q2 | -1.6 Million GBP | 0.0% |
| 2015 Q4 | -5.22 Million GBP | 0.0% |
| 2015 Q2 | -9.58 Million GBP | 0.0% |
| 2015 FY | -5.22 Million GBP | 66.35% |
| 2014 Q4 | -15.51 Million GBP | 0.0% |
| 2014 Q2 | -20.6 Million GBP | 0.0% |
| 2014 FY | -15.51 Million GBP | -1458.54% |
| 2013 FY | -995.64 Thousand GBP | 35.88% |
| 2013 Q4 | -995.64 Thousand GBP | 0.0% |
| 2013 Q2 | -1.41 Million GBP | 0.0% |
| 2012 Q2 | -3.7 Million GBP | 0.0% |
| 2012 FY | -1.55 Million GBP | 60.41% |
| 2012 Q4 | -1.55 Million GBP | 0.0% |
| 2011 FY | -3.92 Million GBP | -26.86% |
| 2011 Q4 | -3.92 Million GBP | 0.0% |
| 2011 Q2 | -1.84 Million GBP | 0.0% |
| 2010 FY | -3.09 Million GBP | 32.44% |
| 2010 Q2 | -4.37 Million GBP | 0.0% |
| 2010 Q4 | -3.09 Million GBP | 0.0% |
| 2009 FY | -4.57 Million GBP | -27.29% |
| 2009 Q2 | -2.75 Million GBP | 0.0% |
| 2009 Q4 | -4.57 Million GBP | 0.0% |
| 2008 Q2 | -6.3 Million GBP | 0.0% |
| 2008 Q4 | -3.59 Million GBP | 0.0% |
| 2008 FY | -3.59 Million GBP | -44.8% |
| 2007 Q4 | -2.48 Million GBP | 0.0% |
| 2007 Q2 | -3.72 Million GBP | 0.0% |
| 2007 FY | -2.48 Million GBP | -19.22% |
| 2006 Q2 | -1.59 Million GBP | 0.0% |
| 2006 Q4 | -2.08 Million GBP | 0.0% |
| 2006 FY | -2.08 Million GBP | -23.25% |
| 2005 FY | -1.68 Million GBP | 0.0% |
| 2005 Q4 | -1.68 Million GBP | 0.0% |
| 2005 Q2 | -1.79 Million GBP | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -294.07% |
| Alkermes plc | -166.73 Million USD | -32.208% |
| Agenus Inc. | 274.13 Million USD | 180.414% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 111.789% |
| Aptorum Group Limited | 1.35 Million USD | 16344.328% |
| Ardelyx, Inc. | 34.51 Million USD | 738.743% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 5250.537% |
| Bicycle Therapeutics plc | -481.46 Million USD | 54.214% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 709.582% |
| ChromaDex Corporation | -24.04 Million USD | -816.679% |
| Chimerix, Inc. | -25.51 Million USD | -763.906% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3263.614% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -831.043% |
| CRISPR Therapeutics AG | -150.84 Million USD | -46.139% |
| Precision BioSciences, Inc. | -85.41 Million USD | -158.1% |
| Dyadic International, Inc. | -6.37 Million USD | -3356.249% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1283.562% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2975.969% |
| Lantern Pharma Inc. | -21.7 Million USD | -915.713% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -99.429% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2480.34% |
| Incyte Corporation | -3.17 Billion USD | 93.057% |
| IO Biotech, Inc. | -140.69 Million USD | -56.677% |
| Jaguar Health, Inc. | 29.39 Million USD | 850.036% |
| Novavax, Inc. | -298.29 Million USD | 26.099% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 4230.467% |
| Opthea Limited | 28.15 Million USD | 882.894% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1213.02% |
| ContextLogic Inc. | -232 Million USD | 4.981% |
| MiMedx Group, Inc. | -33.9 Million USD | -550.255% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2262.266% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -9414.045% |
| NextCure, Inc. | -6.47 Million USD | -3303.474% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -336.512% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3355.761% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1912.367% |
| Vaxcyte, Inc. | -368.22 Million USD | 40.134% |
| PDS Biotechnology Corporation | -32.7 Million USD | -573.954% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1375.859% |
| Pharming Group N.V. | 109.8 Million USD | 300.76% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1167.205% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -25.802% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1090.306% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1090.306% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -3004.831% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3661.826% |
| Acelyrin, Inc. | -216.9 Million USD | -1.632% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3829.278% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -12686.717% |
| Summit Therapeutics Inc. | 34.67 Million USD | 735.759% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -3140.379% |
| Senti Biosciences, Inc. | 1.74 Million USD | 12769.138% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -19.412% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -184.623% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3536.473% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 221053.402% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 35202.389% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -88.339% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -31.034% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 298.83% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2802.093% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -70.735% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3297.329% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 9.044% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1158.97% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 30.394% |
| MEI Pharma, Inc. | -3.7 Million USD | -5849.879% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1861.993% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 236.293% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 893.16% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2975.969% |
| Precigen, Inc. | -481 Thousand USD | -45730.146% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1665.535% |
| AlloVir, Inc. | -62.69 Million USD | -251.629% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -296.38% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 457.479% |
| ImmuCell Corporation | 10.99 Million USD | 2105.748% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -43.009% |
| Onconetix, Inc. | 5.33 Million USD | 4234.776% |
| PureTech Health plc | -167.19 Million USD | -31.846% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -623.713% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1053.065% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -4390.589% |
| Seer, Inc. | -4.24 Million USD | -5099.127% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -817.099% |
| Innoviva, Inc. | 255.56 Million USD | 186.258% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -294.607% |
| ESSA Pharma Inc. | -33.62 Million USD | -555.659% |
| GlycoMimetics, Inc. | -40.98 Million USD | -437.87% |
| GT Biopharma, Inc. | -1.02 Million USD | -21490.891% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -225.219% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 459.866% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -64.413% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1490.957% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -663.518% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -292520.862% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -614.286% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2590.016% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -6945.118% |
| Soligenix, Inc. | -4.95 Million USD | -4351.958% |
| Century Therapeutics, Inc. | 847 Thousand USD | 26126.328% |
| Kura Oncology, Inc. | -20.11 Million USD | -995.75% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -438.638% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2524.946% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 12200.983% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -6795.308% |
| Autolus Therapeutics plc | -186.59 Million USD | -18.137% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -347.11% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 20.07% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 743.291% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 234.116% |
| GRI Bio, Inc. | -1.79 Million USD | -12187.793% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2353.989% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -562.847% |
| IGM Biosciences, Inc. | -72.6 Million USD | -203.615% |
| INmune Bio, Inc. | -25.41 Million USD | -767.51% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 246.036% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -335.151% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1256.625% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -7541.201% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 679.884% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -435.251% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 791.369% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 158.326% |
| Verastem, Inc. | -37.27 Million USD | -491.349% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2329.659% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -325.057% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1356.511% |
| Histogen Inc. | -7.48 Million USD | -2844.344% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -920.247% |
| Surrozen, Inc. | -32.66 Million USD | -574.881% |
| Organovo Holdings, Inc. | -1.5 Million USD | -14527.936% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5144.288% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1262.661% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 8526.72% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 5404.211% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2530.224% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -407.442% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1412.28% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 30.413% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -30429.734% |
| Apollomics, Inc. | -27.39 Million USD | -704.683% |
| Amarin Corporation plc | -191.04 Million USD | -15.391% |
| Mesoblast Limited | 55.96 Million USD | 493.908% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1411.54% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -771.592% |
| Synaptogenix, Inc. | -28.66 Million USD | -669.126% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -23451.603% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 552.358% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -25470.794% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2933.864% |
| Exelixis, Inc. | -73.05 Million USD | -201.77% |
| Better Therapeutics, Inc. | -860 Thousand USD | -25532.907% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -818.015% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 8.67% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 30048.809% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2863.686% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 17679.187% |
| Gritstone bio, Inc. | 39.49 Million USD | 658.225% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -162.117% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -8275.048% |
| Avid Bioservices, Inc. | 169.72 Million USD | 229.88% |
| Insmed Incorporated | 721.62 Million USD | 130.548% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2311.45% |
| MediWound Ltd. | -5.32 Million USD | -4042.108% |
| OmniAb, Inc. | 9.2 Million USD | 2495.338% |
| Alector, Inc. | -35.63 Million USD | -518.579% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 356.416% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -4373.275% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1765.103% |
| Zai Lab Limited | -775 Million USD | 71.556% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 164.731% |
| Aura Biosciences, Inc. | -21.52 Million USD | -924.125% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -167.268% |
| Immunic, Inc. | -45.34 Million USD | -386.2% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -14.092% |
| Veracyte, Inc. | -203.82 Million USD | -8.154% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 134.536% |
| FibroGen, Inc. | 56.76 Million USD | 488.329% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2575.497% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -7697.545% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -10547.63% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.802% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -6498.114% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -32.826% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1334.145% |
| Galecto, Inc. | -21.21 Million USD | -939.041% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -826.815% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 114.046% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -800.797% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1815.73% |
| XBiotech Inc. | -200.02 Million USD | -10.209% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -162.117% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4968.441% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -525.14% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -185.481% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3973.537% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -29.357% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -138.642% |
| Vaxxinity, Inc. | 10.13 Million USD | 2275.711% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 129.941% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1947.29% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -234.227% |
| NexImmune, Inc. | -3.13 Million USD | -6934.72% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -6284.705% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1358.781% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -713.443% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2355.901% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -176856.051% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -443.338% |
| Ainos, Inc. | 4.07 Million USD | 5505.76% |
| Pluri Inc. | 22.82 Million USD | 1065.627% |
| Prothena Corporation plc | -608.34 Million USD | 63.764% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -85.627% |
| Celularity Inc. | 65.19 Million USD | 438.155% |
| Rallybio Corporation | -24.1 Million USD | -814.625% |
| Cue Biopharma, Inc. | -33.81 Million USD | -551.832% |
| MeiraGTx Holdings plc | -40.3 Million USD | -446.978% |
| Omeros Corporation | 331.17 Million USD | 166.564% |
| Humacyte, Inc. | -22.48 Million USD | -880.357% |
| Immunocore Holdings plc | -358.59 Million USD | 38.526% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -797.021% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -613.385% |
| Blueprint Medicines Corporation | 702.83 Million USD | 131.365% |
| CalciMedica, Inc. | -5.53 Million USD | -3886.311% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -17.12% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2058.244% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -450.598% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -562.927% |
| Pulmatrix, Inc. | -10.41 Million USD | -2016.185% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3588.188% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -477.953% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -97.881% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -267.748% |
| Cytokinetics, Incorporated | 642.37 Million USD | 134.317% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3685.729% |
| Nutriband Inc. | -251.65 Thousand USD | -87496.61% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -546.1% |
| Vor Biopharma Inc. | 4.3 Million USD | 5226.581% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.348% |
| Evogene Ltd. | -19.63 Million USD | -1022.762% |
| ProKidney Corp. | -56.23 Million USD | -291.996% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -352.915% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2286.473% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 116.163% |
| CorMedix Inc. | -43.05 Million USD | -412.033% |
| BioLineRx Ltd. | 7.33 Million USD | 3104.948% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -702.632% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 577.697% |
| Atai Life Sciences N.V. | -28.55 Million USD | -671.913% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 9982.992% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -866.177% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1342.983% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -193.634% |
| MediciNova, Inc. | -50.78 Million USD | -334.084% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -179.732% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -979864.437% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3316.35% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -10.32% |
| Biomea Fusion, Inc. | -166.57 Million USD | -32.343% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -23.17% |
| Mereo BioPharma Group plc | -51.46 Million USD | -328.302% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -132.427% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 24.958% |
| Absci Corporation | -72.59 Million USD | -203.649% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4927.924% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 5.969% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -133.989% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -130.358% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -464.182% |
| Allakos Inc. | -24.97 Million USD | -782.655% |
| Imunon, Inc. | -4.21 Million USD | -5131.389% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1395.34% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -62.809% |
| BioAtla, Inc. | -109.01 Million USD | -102.221% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 30048.809% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -23376.358% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1942.245% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -939.678% |
| XOMA Corporation | -29 Million USD | -660.148% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1231.178% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2345.02% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2859.364% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -76.869% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -5.899% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -169.559% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -137.641% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -25557.252% |
| Akari Therapeutics, Plc | -3.84 Million USD | -5633.238% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 13683.361% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 115.964% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -18453.7% |
| UroGen Pharma Ltd. | 4.39 Million USD | 5120.337% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 294.255% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 306432.509% |
| Orgenesis Inc. | 21.78 Million USD | 1111.949% |
| Entera Bio Ltd. | -10.62 Million USD | -1973.977% |
| GH Research PLC | -78.07 Million USD | -182.341% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -889.066% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -726.899% |
| Xencor, Inc. | 29.64 Million USD | 843.634% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -11091.068% |
| Replimune Group, Inc. | 1.41 Million USD | 15712.11% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -89910.535% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -74.378% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -18453.7% |
| Portage Biotech Inc. | -4.98 Million USD | -4325.678% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -979864.437% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -233.388% |
| OncoCyte Corporation | -6.56 Million USD | -3258.876% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 24664.275% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4738.9% |
| Purple Biotech Ltd. | -14.13 Million USD | -1459.223% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -827.947% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3268.113% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1220.638% |
| HilleVax, Inc. | -165.48 Million USD | -33.21% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -8585.697% |
| Tharimmune, Inc. | -10.93 Million USD | -1915.875% |
| Genprex, Inc. | -6.73 Million USD | -3171.819% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 40.228% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -149.201% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -15634.69% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -6545.963% |
| OKYO Pharma Limited | -826.84 Thousand USD | -26560.644% |
| Savara Inc. | 153 Thousand USD | 144180.392% |
| Curis, Inc. | -23.88 Million USD | -822.858% |
| Daré Bioscience, Inc. | -5.15 Million USD | -4173.881% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -28307.164% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3450.95% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 18702.785% |
| BeiGene, Ltd. | -2.25 Billion USD | 90.216% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1886.627% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 63.755% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -18.782% |
| Erasca, Inc. | -37.21 Million USD | -492.334% |
| bluebird bio, Inc. | 108.57 Million USD | 303.04% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -17016.562% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 158.203% |
| DBV Technologies S.A. | -126.98 Million USD | -73.596% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -17016.562% |
| Moderna, Inc. | -2.9 Billion USD | 92.417% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2029.473% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1928.368% |
| Molecular Templates, Inc. | 707 Thousand USD | 31280.057% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -602.697% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 163.6% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -168.63% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -140.317% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -583.078% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -541.27% |
| MacroGenics, Inc. | -66.98 Million USD | -229.093% |
| RenovoRx, Inc. | -1.17 Million USD | -18693.095% |
| Adicet Bio, Inc. | -138.78 Million USD | -58.835% |
| Prime Medicine, Inc. | -27.94 Million USD | -688.959% |
| Aditxt, Inc. | 18.12 Million USD | 1316.513% |
| Adagene Inc. | -87.62 Million USD | -151.569% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5192.205% |
| Quantum-Si incorporated | -118.55 Million USD | -85.938% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 712.257% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2849.391% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -354.437% |
| SciSparc Ltd. | -2.06 Million USD | -10575.206% |
| Vericel Corporation | 1.27 Million USD | 17362.569% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1738.296% |
| Minerva Neurosciences, Inc. | 41 Million USD | 637.61% |
| Generation Bio Co. | 31.44 Million USD | 800.976% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -25.706% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -612.877% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 289.071% |
| Invivyd, Inc. | -198.47 Million USD | -11.068% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -144.204% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -9093.981% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -211.404% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -3129.934% |
| 2seventy bio, Inc. | 181.71 Million USD | 221.312% |
| ADMA Biologics, Inc. | 90.06 Million USD | 344.757% |
| Clene Inc. | 3.34 Million USD | 6700.09% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2327.064% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -924.792% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3316.35% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 35.941% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -747.868% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 224.077% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -5287.74% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 4507.097% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -4131.964% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -69.176% |
| Evaxion Biotech A/S | 5.28 Million USD | 4269.652% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -95.831% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -67.927% |
| Trevena, Inc. | 2.25 Million USD | 9862.755% |
| Surrozen, Inc. | -32.66 Million USD | -574.881% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -327.962% |
| Cingulate Inc. | 3.08 Million USD | 7251.011% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -7405.72% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 3167.246% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2272.593% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -177.906% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -67.698% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -108.868% |
| Clearmind Medicine Inc. | -3.94 Million USD | -5491.258% |
| Kronos Bio, Inc. | -36.05 Million USD | -511.425% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2442.895% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 15218.23% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -306.302% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1629.112% |
| ImmunityBio, Inc. | 618.22 Million USD | 135.657% |
| Korro Bio, Inc. | -132.94 Million USD | -65.818% |
| Kineta, Inc. | -4.54 Million USD | -4754.503% |
| BioVie Inc. | -17.73 Million USD | -1143.168% |
| Codexis, Inc. | -43.27 Million USD | -409.447% |
| Celularity Inc. | 65.19 Million USD | 438.155% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -6856.232% |
| Celcuity Inc. | 6.78 Million USD | 3349.69% |
| Virax Biolabs Group Limited | -3.36 Million USD | -6451.164% |
| Cibus, Inc. | -8.07 Million USD | -2628.93% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -5112.651% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4923.698% |
| IN8bio, Inc. | -16.38 Million USD | -1245.067% |
| Kodiak Sciences Inc. | -103.87 Million USD | -112.219% |
| Annexon, Inc. | -193.75 Million USD | -13.774% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 612441.667% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1159.746% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -6175.064% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 120.909% |
| Eyenovia, Inc. | 1.25 Million USD | 17613.518% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 919.338% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6697.502% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -563.046% |
| Arcellx, Inc. | -296.95 Million USD | 25.766% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1030.129% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -274.425% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -963.555% |
| Moolec Science SA | 117.61 Thousand USD | 187526.03% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -474.085% |
| Geron Corporation | 14.76 Million USD | 1593.415% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -481.368% |
| Royalty Pharma plc | 5.65 Billion USD | 103.896% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -55.877% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -3053.951% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -4010.55% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -56.641% |
| Humacyte, Inc. | -22.48 Million USD | -880.357% |
| Structure Therapeutics Inc. | -124.33 Million USD | -77.292% |
| 89bio, Inc. | -289.05 Million USD | 23.736% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -773.318% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -12263.601% |
| Genelux Corporation | -6.89 Million USD | -3095.289% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -609.756% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 363.691% |
| Notable Labs, Ltd. | -9.77 Million USD | -2154.941% |
| Liquidia Corporation | -80.17 Million USD | -174.949% |
| Mustang Bio, Inc. | -3.73 Million USD | -5800.509% |
| Immunovant, Inc. | -635.22 Million USD | 65.297% |
| Quantum-Si incorporated | -118.55 Million USD | -85.938% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1155.084% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -5220.854% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2846.269% |
| Acasti Pharma Inc. | -23 Million USD | -858.24% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -6446.718% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1256.625% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -60.043% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -6973.729% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -891.557% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1087.156% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -30.225% |
| PepGen Inc. | -60.67 Million USD | -263.348% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -859.449% |
| United Therapeutics Corporation | -507.7 Million USD | 56.58% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1052.583% |
| Solid Biosciences Inc. | -47.75 Million USD | -361.661% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -25470.794% |
| Immuneering Corporation | -54.94 Million USD | -301.222% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5144.288% |
| Silo Pharma, Inc. | -3.52 Million USD | -6154.93% |
| Belite Bio, Inc | -87.27 Million USD | -152.596% |
| XOMA Corporation | -29 Million USD | -660.148% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -211.814% |
| Bionomics Limited | 227 Million USD | 197.107% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -89.576% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -8602.842% |
| uniQure N.V. | -102.95 Million USD | -114.124% |
| Cassava Sciences, Inc. | -121.13 Million USD | -81.98% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5192.205% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 638.309% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1743.015% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -7024.394% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 208065.094% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6697.502% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2575.497% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2872.532% |
| Altimmune, Inc. | -134.48 Million USD | -63.914% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 211.298% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -8602.842% |
| Compugen Ltd. | -12.9 Million USD | -1608.331% |
| Peak Bio, Inc. | 10.34 Million USD | 2231.911% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -77795.053% |
| Benitec Biopharma Inc. | -50.58 Million USD | -335.813% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -111.278% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1222.133% |
| Zura Bio Limited | -99.8 Million USD | -120.871% |
| PolyPid Ltd. | 6.17 Million USD | 3672.82% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 397.414% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1222.133% |
| Instil Bio, Inc. | 75.35 Million USD | 392.528% |
| argenx SE | -2.02 Billion USD | 89.135% |
| Immunome, Inc. | -97.02 Million USD | -127.193% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -879.964% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -207.268% |
| Shattuck Labs, Inc. | -121.42 Million USD | -81.548% |
| CervoMed Inc. | -7.79 Million USD | -2728.787% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -18.838% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4941.002% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -67.332% |
| Moolec Science SA | 117.61 Thousand USD | 187526.03% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -9534.843% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1486.575% |
| AnaptysBio, Inc. | -18.15 Million USD | -1114.495% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1114.562% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -213.214% |
| NeurAxis, Inc. | 145.7 Thousand USD | 151399.245% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2062.634% |
| Lumos Pharma, Inc. | -28.49 Million USD | -673.674% |
| Achilles Therapeutics plc | -126.92 Million USD | -73.681% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -207.268% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -33517.953% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -961.157% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 15218.23% |
| Nutriband Inc. | -251.65 Thousand USD | -87496.61% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1573.7% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2862.944% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 164.799% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1028.768% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 50.736% |
| Palisade Bio, Inc. | -12.06 Million USD | -1727.431% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -57.11% |
| Beam Therapeutics Inc. | -262.72 Million USD | 16.093% |
| Neurogene Inc. | -131.95 Million USD | -67.059% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1110.465% |
| AEON Biopharma, Inc. | -4.88 Million USD | -4417.275% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 41.557% |
| Sesen Bio, Inc. | -112.55 Million USD | -95.857% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -120.752% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -9289.371% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -464.862% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -164.695% |
| Athira Pharma, Inc. | -88.99 Million USD | -147.692% |
| Vaccinex, Inc. | -1.28 Million USD | -17015.14% |
| HCW Biologics Inc. | 2.85 Million USD | 7816.766% |
| XOMA Corporation | -29 Million USD | -660.148% |
| Nektar Therapeutics | 210.24 Million USD | 204.853% |
| Arvinas, Inc. | -313.8 Million USD | 29.75% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 13683.361% |
| Merus N.V. | -192.88 Million USD | -14.288% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 467.497% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -3077.328% |
| Rezolute, Inc. | -68.16 Million USD | -223.382% |
| Clene Inc. | 3.34 Million USD | 6700.09% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1571.669% |
| BeyondSpring Inc. | -13.75 Million USD | -1502.639% |
| Synlogic, Inc. | -6.68 Million USD | -3197.577% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 19539.418% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2507.25% |
| Peak Bio, Inc. | 10.34 Million USD | 2231.911% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -167.463% |
| Krystal Biotech, Inc. | -350.23 Million USD | 37.058% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 277.598% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -30.443% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -6882.355% |
| MannKind Corporation | 143.89 Million USD | 253.193% |
| Ikena Oncology, Inc. | -109.15 Million USD | -101.952% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2811.676% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -565.991% |
| Gossamer Bio, Inc. | 180.35 Million USD | 222.227% |
| CohBar, Inc. | -5.93 Million USD | -3616.962% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -641.035% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4927.924% |
| Legend Biotech Corporation | -949.39 Million USD | 76.781% |
| Mural Oncology plc | -255.84 Million USD | 13.837% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 784.287% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -4579.681% |
| Disc Medicine, Inc. | -358.28 Million USD | 38.472% |
| Champions Oncology, Inc. | 4.81 Million USD | 4681.11% |
| REGENXBIO Inc. | 54.76 Million USD | 502.503% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -81877.412% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -45.966% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2346.104% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -173.221% |
| Vaxart, Inc. | -8.24 Million USD | -2574.954% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -339.305% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -73.351% |
| Cellectis S.A. | -43.85 Million USD | -402.663% |
| Longeveron Inc. | -2.9 Million USD | -7480.571% |
| Repare Therapeutics Inc. | -107.85 Million USD | -104.383% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 122.764% |
| Inozyme Pharma, Inc. | 12 Million USD | 1936.413% |
| Revolution Medicines, Inc. | -608.2 Million USD | 63.755% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -17822.195% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 16.851% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -46.891% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1308.852% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -29689.595% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.695% |
| Denali Therapeutics Inc. | -74.86 Million USD | -194.454% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1738.296% |
| Veru Inc. | 4.77 Million USD | 4711.808% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1860.19% |
| Cingulate Inc. | 3.08 Million USD | 7251.011% |
| Passage Bio, Inc. | 4.58 Million USD | 4907.917% |
| Context Therapeutics Inc. | -14.44 Million USD | -1425.575% |
| Exicure, Inc. | 5.84 Million USD | 3868.901% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 4.312% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -457.096% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1504.901% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -274.769% |
| Nuvalent, Inc. | -335.38 Million USD | 34.272% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 12810.476% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -195.968% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2379.674% |
| OmniAb, Inc. | 9.2 Million USD | 2495.338% |
| Anew Medical, Inc. | 1.43 Million USD | 15489.067% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1445.662% |
| Lipocine Inc. | -4.75 Million USD | -4536.423% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -100.717% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1547.331% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -335.151% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 985.598% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -3179.914% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -234.882% |
| Ocugen, Inc. | -32.52 Million USD | -577.848% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -157.602% |
| Q32 Bio Inc. | -37.94 Million USD | -480.908% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -35002.389% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1529.411% |
| Equillium, Inc. | -22.39 Million USD | -884.472% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -762.183% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -575.651% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -88818.783% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 264.458% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 6993.152% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 67217.991% |
| Dominari Holdings Inc. | 195 Thousand USD | 113147.692% |
| Edesa Biotech, Inc. | -5.26 Million USD | -4085.433% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2372.166% |
| Bio-Techne Corporation | 267.74 Million USD | 182.333% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1260.004% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -86.667% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2523.385% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1642.495% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 10.067% |
| Nkarta, Inc. | 57.29 Million USD | 484.724% |
| BioCardia, Inc. | 212 Thousand USD | 104082.547% |
| Iterum Therapeutics plc | 13.43 Million USD | 1740.445% |